| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
31,003 |
26,446 |
$3.78M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,884 |
12,008 |
$2.63M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,349 |
6,452 |
$1.06M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,598 |
4,380 |
$940K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,814 |
4,509 |
$876K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,688 |
1,734 |
$870K |
| 36415 |
Collection of venous blood by venipuncture |
9,784 |
8,709 |
$681K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,764 |
1,592 |
$611K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,255 |
3,019 |
$520K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,270 |
2,096 |
$361K |
| 80053 |
Comprehensive metabolic panel |
11,537 |
10,394 |
$323K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,515 |
2,452 |
$278K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
552 |
540 |
$150K |
| 70450 |
Computed tomography, head or brain; without contrast material |
421 |
414 |
$141K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,001 |
871 |
$138K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
672 |
647 |
$120K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,790 |
1,729 |
$114K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,669 |
914 |
$99K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
868 |
811 |
$94K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
833 |
820 |
$91K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
319 |
265 |
$69K |
| 81025 |
|
1,340 |
1,297 |
$55K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,257 |
1,903 |
$52K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
177 |
176 |
$50K |
| 80061 |
Lipid panel |
3,633 |
3,611 |
$48K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
250 |
250 |
$46K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,342 |
1,326 |
$45K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
140 |
133 |
$44K |
| 97014 |
|
484 |
156 |
$32K |
| 36416 |
|
322 |
275 |
$31K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
193 |
193 |
$31K |
| 97162 |
|
105 |
105 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,184 |
10,522 |
$30K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,872 |
3,786 |
$29K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,334 |
3,294 |
$22K |
| 90686 |
|
1,090 |
1,086 |
$21K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
334 |
330 |
$18K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
69 |
69 |
$13K |
| 99441 |
|
318 |
289 |
$10K |
| 84439 |
|
1,305 |
1,277 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,478 |
2,223 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
1,941 |
1,864 |
$9K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
662 |
659 |
$9K |
| 90715 |
|
249 |
249 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
35 |
35 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
437 |
427 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
333 |
325 |
$7K |
| 99215 |
Prolong outpt/office vis |
45 |
42 |
$7K |
| 86618 |
|
618 |
612 |
$7K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
53 |
52 |
$6K |
| 80306 |
|
1,757 |
1,599 |
$6K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
72 |
24 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
65 |
63 |
$5K |
| 99442 |
|
68 |
63 |
$5K |
| 82607 |
|
413 |
411 |
$5K |
| 87070 |
|
864 |
836 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,057 |
1,811 |
$4K |
| 92551 |
|
60 |
60 |
$4K |
| 83735 |
|
2,483 |
2,148 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,743 |
2,482 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
77 |
76 |
$4K |
| 87468 |
|
142 |
141 |
$4K |
| 82728 |
|
377 |
367 |
$4K |
| 81001 |
|
3,074 |
2,801 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
456 |
376 |
$3K |
| 87469 |
|
132 |
130 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,741 |
1,679 |
$3K |
| 96127 |
|
158 |
152 |
$3K |
| 87484 |
|
143 |
142 |
$3K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
72 |
72 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,550 |
1,323 |
$3K |
| 86140 |
|
836 |
794 |
$3K |
| 83690 |
|
2,031 |
1,715 |
$3K |
| 83880 |
|
84 |
76 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
98 |
96 |
$2K |
| 73630 |
|
258 |
250 |
$2K |
| 83540 |
|
473 |
460 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
65 |
64 |
$2K |
| 85610 |
|
670 |
571 |
$2K |
| 82746 |
|
129 |
129 |
$2K |
| 87088 |
|
381 |
340 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
65 |
63 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
146 |
143 |
$1K |
| 84484 |
|
1,758 |
1,445 |
$1K |
| 83550 |
|
275 |
267 |
$1K |
| 71045 |
Radiologic examination, chest; single view |
663 |
632 |
$1K |
| 86617 |
|
58 |
58 |
$1K |
| 73030 |
|
120 |
118 |
$1K |
| 87186 |
|
428 |
409 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
521 |
493 |
$1K |
| 85651 |
|
311 |
305 |
$1K |
| 87184 |
|
388 |
334 |
$1K |
| 86803 |
|
189 |
186 |
$1K |
| 90656 |
|
85 |
85 |
$1K |
| 85027 |
|
465 |
400 |
$978.95 |
| 87081 |
|
440 |
426 |
$950.66 |
| 90734 |
|
36 |
36 |
$948.96 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
756 |
643 |
$941.50 |
| 73610 |
|
279 |
272 |
$896.82 |
| 87077 |
|
183 |
170 |
$702.08 |
| 83605 |
|
918 |
815 |
$688.63 |
| 82043 |
|
169 |
156 |
$658.39 |
| 84702 |
|
118 |
103 |
$626.56 |
| 82150 |
|
357 |
343 |
$533.97 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
320 |
309 |
$492.02 |
| 81003 |
|
976 |
935 |
$488.01 |
| 90677 |
|
13 |
13 |
$413.17 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
302 |
272 |
$392.94 |
| 73110 |
|
68 |
65 |
$322.98 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
206 |
204 |
$320.93 |
| 73564 |
|
85 |
82 |
$317.73 |
| 73130 |
|
69 |
66 |
$308.28 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
660 |
654 |
$301.54 |
| 82570 |
|
97 |
80 |
$265.81 |
| 86141 |
|
250 |
242 |
$263.33 |
| 85379 |
|
159 |
157 |
$169.50 |
| 87040 |
|
194 |
121 |
$166.40 |
| 82248 |
|
30 |
27 |
$80.10 |
| 84703 |
|
38 |
37 |
$79.11 |
| 90461 |
|
25 |
25 |
$71.60 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
276 |
273 |
$70.41 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
561 |
522 |
$63.40 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,956 |
1,269 |
$57.44 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
610 |
570 |
$54.88 |
| 81002 |
|
51 |
48 |
$47.79 |
| 86756 |
|
14 |
14 |
$41.75 |
| 85730 |
|
37 |
37 |
$40.46 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
51 |
41 |
$32.09 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
17 |
17 |
$31.82 |
| 86038 |
|
12 |
12 |
$24.84 |
| 86753 |
|
15 |
15 |
$24.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
97 |
93 |
$24.21 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
912 |
782 |
$23.41 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
24 |
24 |
$22.98 |
| 85652 |
|
12 |
12 |
$21.23 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
28 |
24 |
$8.48 |
| 82962 |
|
226 |
158 |
$4.60 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
150 |
146 |
$2.15 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
99 |
96 |
$0.40 |